Changes to the Code
H.R. 1497 · NIH Reform Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 281 Organization of National Institutes of Health
4 changes the bill asks for here, 4 carried out
- Carried out:
in paragraph (6), by striking
Allergy and Infectious Diseases
and insertingAllergic Diseases
; - Carried out:
by redesignating paragraph (25) as paragraph (27); and
- Carried out:
by inserting after paragraph (24) the following:
(25) The National Institute of Infectious Diseases. (26) The National Institute of Immunologic Diseases.; and
- Carried out:
in subsection (d)(1), by striking
27
and inserting29
.
§ 281(b)National research institutes and national centers(5)–(8)
Start of § 281 to (b)(4) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (5) | (5) | (5) | ||
| The National Institute on Aging. | The National Institute on Aging. | |||
| (6) | (6) | (6) | ||
| The National Institute of | The National Institute of [inserted: Allergic] Diseases. | |||
| (7) | (7) | (7) | ||
| The Eunice Kennedy Shriver National Institute of Child Health and Human Development. | The Eunice Kennedy Shriver National Institute of Child Health and Human Development. | |||
| (8) | (8) | (8) | ||
| The National Institute of Dental and Craniofacial Research. | The National Institute of Dental and Craniofacial Research. |
§ 281(b)–(c)
(b)(9)–(22) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (b)(23) | (23) | (23) | ||
| The National Center for Complementary and Integrative Health. | The National Center for Complementary and Integrative Health. | |||
| (b)(24) | (24) | (24) | ||
| The National Institute on Minority Health and Health Disparities. | The National Institute on Minority Health and Health Disparities. | |||
| (b)(25) | (25) [inserted: ] | |||
| [inserted: The National Institute of Infectious Diseases.] | ||||
| (b)(26) | (26) [inserted: ] | |||
| [inserted: The National Institute of Immunologic Diseases.] | ||||
| (b)(27) | [inserted: (27)] | |||
| Any other national center that, as an agency separate from any national research institute, was established within the National Institutes of Health as of the day before January 15, 2007. | Any other national center that, as an agency separate from any national research institute, was established within the National Institutes of Health as of the day before January 15, 2007. | |||
| (c) | (c) Division of Program Coordination, Planning, and Strategic Initiatives | (c) Division of Program Coordination, Planning, and Strategic Initiatives | ||
| (c)(1) | (1) In general | (1) In general | ||
| Within the Office of the Director of the National Institutes of Health, there shall be a Division of Program Coordination, Planning, and Strategic Initiatives (referred to in this subsection as the “Division”). | Within the Office of the Director of the National Institutes of Health, there shall be a Division of Program Coordination, Planning, and Strategic Initiatives (referred to in this subsection as the “Division”). | |||
§ 281(c)–(d)
(c)(2) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (c)(2)(B)(ii) | (ii) | (ii) | ||
| shall, as determined appropriate by the Director of NIH, support the Division with respect to the authorities described in section 282(b)(7) of this title. | shall, as determined appropriate by the Director of NIH, support the Division with respect to the authorities described in section 282(b)(7) of this title. | |||
| (d) | (d) Organization | (d) Organization | ||
| (d)(1) | (1) Number of institutes and centers | (1) Number of institutes and centers | ||
| In the National Institutes of Health, the number of national research institutes and national centers may not exceed a total of | In the National Institutes of Health, the number of national research institutes and national centers may not exceed a total of [inserted: 29], including any such institutes or centers established under authority of paragraph (2) or under authority of this subchapter as in effect on the day before January 15, 2007. | |||
| (d)(2) | (2) Reorganization of institutes | (2) Reorganization of institutes | ||
| (d)(2)(A) | (A) In general | (A) In general | ||
| The Secretary may establish in the National Institutes of Health one or more additional national research institutes to conduct and support research, training, health information, and other programs with respect to any particular disease or groups of diseases or any other aspect of human health if— | The Secretary may establish in the National Institutes of Health one or more additional national research institutes to conduct and support research, training, health information, and other programs with respect to any particular disease or groups of diseases or any other aspect of human health if— |
Rest of § 281 unchanged
42 U.S.C. § 283d Children’s Vaccine Initiative
1 change the bill asks for here, 1 carried out
- Carried out:
Section 404B of the Public Health Service Act (42 U.S.C. 283d) is amended by striking
National Institute for Allergy and Infectious Diseases
and insertingNational Institute of Infectious Diseases
.
§ 283d
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 283d. Children’s Vaccine Initiative | § 283d. Children’s Vaccine Initiative | |||
| The Secretary, in consultation with the Director of the National Vaccine Program under subchapter XIX and acting through the Directors of the National Institute | The Secretary, in consultation with the Director of the National Vaccine Program under subchapter XIX and acting through the Directors of the National Institute [inserted: of] Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute for Aging, and other public and private programs, shall carry out activities, which shall be consistent with the global Children’s Vaccine Initiative, to develop affordable new and improved vaccines to be used in the United States and in the developing world that will increase the efficacy and efficiency of the prevention of infectious diseases. In carrying out such activities, the Secretary shall, to the extent practicable, develop and make available vaccines that require fewer contacts to deliver, that can be given early in life, that provide long lasting protection, that obviate refrigeration, needles and syringes, and that protect against a larger number of diseases. |
42 U.S.C. § 283k Biomedical and behavioral research facilities
2 changes the bill asks for here, 2 carried out
- Carried out:
in subsection (a)(1), by striking
or the Director of the National Institute of Allergy and Infectious Diseases
; and - Carried out:
by striking
or the National Institute of Allergy and Infectious Diseases
each place it appears.
§ 283k(a)–(b)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 283k. Biomedical and behavioral research facilities | § 283k. Biomedical and behavioral research facilities | |||
| (a) | (a) Modernization and construction of facilities | (a) Modernization and construction of facilities | ||
| (a)(1) | (1) In general | (1) In general | ||
| The Director of NIH, acting through the Office of the Director of NIH | The Director of NIH, acting through the Office of the Director of NIH , may make grants or contracts to public and nonprofit private entities to expand, remodel, renovate, or alter existing research facilities or construct new research facilities, subject to the provisions of this section. | |||
| (a)(2) | (2) Construction and cost of construction | (2) Construction and cost of construction | ||
| For purposes of this section, the terms “construction” and “cost of construction” include the construction of new buildings and the expansion, renovation, remodeling, and alteration of existing buildings, including architects’ fees, but do not include the cost of acquisition of land or off-site improvements. | For purposes of this section, the terms “construction” and “cost of construction” include the construction of new buildings and the expansion, renovation, remodeling, and alteration of existing buildings, including architects’ fees, but do not include the cost of acquisition of land or off-site improvements. | |||
| (b) | (b) Scientific and technical review boards for merit-based review of proposals | (b) Scientific and technical review boards for merit-based review of proposals |
§ 283k(b)–(c)
(b)(1)–(6) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (b)(7) | (7) Compensation | (7) Compensation | ||
| Members of the Board who are not officers or employees of the United States shall receive for each day the members are engaged in the performance of the functions of the Board compensation at the same rate received by members of other national advisory councils established under this subchapter. | Members of the Board who are not officers or employees of the United States shall receive for each day the members are engaged in the performance of the functions of the Board compensation at the same rate received by members of other national advisory councils established under this subchapter. | |||
| (c) | (c) Requirements for grants | (c) Requirements for grants | ||
| (c)(1) | (1) In general | (1) In general | ||
| The Director of NIH, acting through the Office of the Director of NIH | The Director of NIH, acting through the Office of the Director of NIH , may make a grant under subsection (a) only if the applicant for the grant meets the following conditions: | |||
| (c)(1)(A) | (A) | (A) | ||
| The applicant is determined by such Director to be competent to engage in the type of research for which the proposed facility is to be constructed. | The applicant is determined by such Director to be competent to engage in the type of research for which the proposed facility is to be constructed. | |||
| (c)(1)(B) | (B) | (B) | ||
| The applicant provides assurances satisfactory to the Director that— | The applicant provides assurances satisfactory to the Director that— |
§ 283k(c)–(g)
(c)(1)(B)(i)–(2)(D)(ii) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (c)(2)(D)(iii) | (iii) | (iii) | ||
| is located in a geographic area in which a deficit in health care technology, services, or research resources may adversely affect the health status of the population of the area in the future, and the applicant is carrying out activities with respect to protecting the health status of such population. | is located in a geographic area in which a deficit in health care technology, services, or research resources may adversely affect the health status of the population of the area in the future, and the applicant is carrying out activities with respect to protecting the health status of such population. | |||
| (d) | (d) Requirement of application | (d) Requirement of application | ||
| The Director of NIH, acting through the Office of the Director of NIH | The Director of NIH, acting through the Office of the Director of NIH , may make a grant under subsection (a) only if an application for the grant is submitted to the Director and the application is in such form, is made in such manner, and contains such agreements, assurances, and information as the Director determines to be necessary to carry out this section. | |||
| (e) | (e) Amount of grant; payments | (e) Amount of grant; payments | ||
| (e)(1) | (1) Amount | (1) Amount | ||
| The amount of any grant awarded under subsection (a) shall be determined by the Director of NIH, acting through the Office of the Director of NIH | The amount of any grant awarded under subsection (a) shall be determined by the Director of NIH, acting through the Office of the Director of NIH ,, except that such amount shall not exceed— | |||
| (e)(1)(A) | (A) | (A) | ||
| 50 percent (or, in the case of the Institute, 75 percent) of the necessary cost of the construction of a proposed facility as determined by the Director; or | 50 percent (or, in the case of the Institute, 75 percent) of the necessary cost of the construction of a proposed facility as determined by the Director; or | |||
| (e)(1)(B) | (B) | (B) | ||
| in the case of a multipurpose facility, 40 percent (or, in the case of the Institute, 75 percent) of that part of the necessary cost of construction that the Director determines to be proportionate to the contemplated use of the facility. | in the case of a multipurpose facility, 40 percent (or, in the case of the Institute, 75 percent) of that part of the necessary cost of construction that the Director determines to be proportionate to the contemplated use of the facility. | |||
| (e)(2) | (2) Reservation of amounts | (2) Reservation of amounts | ||
| On the approval of any application for a grant under subsection (a), the Director of NIH, acting through the Office of the Director of NIH | On the approval of any application for a grant under subsection (a), the Director of NIH, acting through the Office of the Director of NIH , shall reserve, from any appropriation available for such grants, the amount of such grant, and shall pay such amount, in advance or by way of reimbursement, and in such installments consistent with the construction progress, as the Director may determine appropriate. The reservation of any amount by the Director under this paragraph may be amended by the Director, either on the approval of an amendment of the application or on the revision of the estimated cost of construction of the facility. | |||
| (e)(3) | (3) Exclusion of certain costs | (3) Exclusion of certain costs | ||
| In determining the amount of any grant under subsection (a), there shall be excluded from the cost of construction an amount equal to the sum of— | In determining the amount of any grant under subsection (a), there shall be excluded from the cost of construction an amount equal to the sum of— | |||
| (e)(3)(A) | (A) | (A) | ||
| the amount of any other Federal grant that the applicant has obtained, or is assured of obtaining, with respect to construction that is to be financed in part by a grant authorized under this section; and | the amount of any other Federal grant that the applicant has obtained, or is assured of obtaining, with respect to construction that is to be financed in part by a grant authorized under this section; and | |||
| (e)(3)(B) | (B) | (B) | ||
| the amount of any non-Federal funds required to be expended as a condition of such other Federal grant. | the amount of any non-Federal funds required to be expended as a condition of such other Federal grant. | |||
| (e)(4) | (4) Waiver of limitations | (4) Waiver of limitations | ||
| The limitations imposed under paragraph (1) may be waived at the discretion of the Director of NIH, acting through the Office of the Director of NIH | The limitations imposed under paragraph (1) may be waived at the discretion of the Director of NIH, acting through the Office of the Director of NIH , for applicants meeting the conditions described in subsection (c). | |||
| (f) | (f) Recapture of payments | (f) Recapture of payments | ||
| If, not later than 20 years after the completion of construction for which a grant has been awarded under subsection (a)— | If, not later than 20 years after the completion of construction for which a grant has been awarded under subsection (a)— | |||
| (f)(1) | (1) | (1) | ||
| in the case of an award by the Director of NIH, acting through the Office of the Director of NIH, the applicant or other owner of the facility shall cease to be a public or non profit3 private entity; or | in the case of an award by the Director of NIH, acting through the Office of the Director of NIH, the applicant or other owner of the facility shall cease to be a public or non profit3 private entity; or | |||
| (f)(2) | (2) | (2) | ||
| the facility shall cease to be used for the research purposes for which it was constructed (unless the Director of NIH, acting through the Office of the Director of NIH | the facility shall cease to be used for the research purposes for which it was constructed (unless the Director of NIH, acting through the Office of the Director of NIH , determines, in accordance with regulations, that there is good cause for releasing the applicant or other owner from obligation to do so), | |||
| (f) | the United States shall be entitled to recover from the applicant or other owner of the facility the amount bearing the same ratio to the current value (as determined by an agreement between the parties or by action brought in the United States District Court for the district in which such facility is situated) of the facility as the amount of the Federal participation bore to the cost of the construction of such facility. | the United States shall be entitled to recover from the applicant or other owner of the facility the amount bearing the same ratio to the current value (as determined by an agreement between the parties or by action brought in the United States District Court for the district in which such facility is situated) of the facility as the amount of the Federal participation bore to the cost of the construction of such facility. | ||
| (g) | (g) Guidelines | (g) Guidelines | ||
| Not later than 6 months after June 10, 1993, the Director of NIH, acting through the Office of the Director of NIH, after consultation with the Council, shall issue guidelines with respect to grants under subsection (a). | Not later than 6 months after June 10, 1993, the Director of NIH, acting through the Office of the Director of NIH, after consultation with the Council, shall issue guidelines with respect to grants under subsection (a). |
42 U.S.C. § 284 Directors of national research institutes
3 changes the bill asks for here, 3 carried out
- Carried out:
by inserting
, the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases
afterNational Cancer Institute
; and - Carried out:
by inserting
by and with the advice and consent of the Senate,
afterthe President,
. - Carried out:
Section 405(a) of the Public Health Service Act (42 U.S.C. 284(a)) is amended by adding at the end the following:
(4) Certain appointments by the President.— The appointments by the President of the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases shall …
§ 284(a)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 284. Directors of national research institutes | § 284. Directors of national research institutes | |||
| (a) | (a) Appointment | (a) Appointment | ||
| (a)(1) | (1) In general | (1) In general | ||
| The Director of the National Cancer Institute shall be appointed by the President, and the Directors of the other national research institutes and national centers shall be appointed by the Secretary, acting through the Director of National Institutes of Health. Each Director of a national research institute or national center shall report directly to the Director of National Institutes of Health. | The Director of the National Cancer Institute[inserted: ,] [inserted: the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases ]shall be appointed by the President, [inserted: by ]and [inserted: with ]the [inserted: advice and consent of the Senate, and the ]Directors of the other national research institutes and national centers shall be appointed by the Secretary, acting through the Director of National Institutes of Health. Each Director of a national research institute or national center shall report directly to the Director of National Institutes of Health. | |||
| (a)(2) | (2) Appointment | (2) Appointment | ||
| (a)(2)(A) | (A) Term | (A) Term | ||
| A Director of a national research institute or national center who is appointed by the Secretary, acting through the Director of National Institutes of Health, shall be appointed for 5 years. | A Director of a national research institute or national center who is appointed by the Secretary, acting through the Director of National Institutes of Health, shall be appointed for 5 years. |
§ 284(a)–(b)
(a)(2)(B)–(E) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (a)(2)(F) | (F) Nature of appointment | (F) Nature of appointment | ||
| Appointments and reappointments under this subsection shall be made on the basis of ability and experience as it relates to the mission of the National Institutes of Health and its components, including compliance with any legal requirement that the Secretary or Director of National Institutes of Health determines relevant. | Appointments and reappointments under this subsection shall be made on the basis of ability and experience as it relates to the mission of the National Institutes of Health and its components, including compliance with any legal requirement that the Secretary or Director of National Institutes of Health determines relevant. | |||
| (a)(3) | (3) Nonapplication of certain provision | (3) Nonapplication of certain provision | ||
| The restrictions contained in section 202 of the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 1993 (Public Law 102–394; 42 U.S.C. 238f note) related to consultants and individual scientists appointed for limited periods of time shall not apply to Directors appointed under this subsection. | The restrictions contained in section 202 of the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 1993 (Public Law 102–394; 42 U.S.C. 238f note) related to consultants and individual scientists appointed for limited periods of time shall not apply to Directors appointed under this subsection. | |||
| (a)(4) | (4) [inserted: Certain appointments by the President.—] | |||
| [inserted: The appointments by the President of the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases shall be for terms of 5 years. Each such Director may be reappointed for not more than 1 additional term, in accordance paragraph (1).] | ||||
| (b) | (b) Duties and authority; grants, contracts, and cooperative agreements | (b) Duties and authority; grants, contracts, and cooperative agreements | ||
| (b)(1) | (1) | (1) | ||
| In carrying out the purposes of section 241 of this title with respect to human diseases or disorders or other aspects of human health for which the national research institutes were established, the Secretary, acting through the Director of each national research institute— | In carrying out the purposes of section 241 of this title with respect to human diseases or disorders or other aspects of human health for which the national research institutes were established, the Secretary, acting through the Director of each national research institute— | |||
Rest of § 284 unchanged
42 U.S.C. § 285d–8 Juvenile arthritis and related conditions
1 change the bill asks for here, 1 carried out
- Carried out:
Section 442A(a) of the Public Health Service Act (42 U.S.C. 285d–8(a)) is amended by striking
Allergy and Infectious Diseases
and insertingImmunologic Diseases
.
§ 285d–8(a)–(b)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 285d–8. Juvenile arthritis and related conditions | § 285d–8. Juvenile arthritis and related conditions | |||
| (a) | (a) Expansion and coordination of activities | (a) Expansion and coordination of activities | ||
| The Director of the Institute, in coordination with the Director of the National Institute of | The Director of the Institute, in coordination with the Director of the National Institute of [inserted: Immunologic] Diseases, shall expand and intensify the programs of such Institutes with respect to research and related activities concerning juvenile arthritis and related conditions. | |||
| (b) | (b) Coordination | (b) Coordination | ||
| The Directors referred to in subsection (a) shall jointly coordinate the programs referred to in such subsection and consult with the Arthritis and Musculoskeletal Diseases Interagency Coordinating Committee. | The Directors referred to in subsection (a) shall jointly coordinate the programs referred to in such subsection and consult with the Arthritis and Musculoskeletal Diseases Interagency Coordinating Committee. |
42 U.S.C. § 285f Purpose of Institute
2 changes the bill asks for here, 2 carried out
- Carried out:
by striking
Allergy and Infectious Diseases
and insertingAllergic Diseases
; and - Carried out:
by striking
allergic and immunologic diseases and disorders and infectious diseases, including tropical diseases
and insertingallergic diseases and disorders
.
§ 285f
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 285f. Purpose of Institute | § 285f. Purpose of Institute | |||
| The general purpose of the National Institute of | The general purpose of the National Institute of [inserted: Allergic] Diseases is the conduct and support of research, training, health information dissemination, and other programs with respect to allergic diseases and disorders. |